A new CEO has been announced by the Christopher & Dana Reeve Foundation to help advance its efforts to find a cure for spinal cord injury even further.
Margaret (Maggie) Goldberg becomes President and CEO of the Foundation, having long served on its leadership committee and helping to drive its mission by advancing innovative research and improving the quality of life for individuals and families impacted by paralysis.
In her new role, she will unveil a fresh approach to the Foundation’s research portfolio and establish new collaborative partnerships to bring greater awareness and attention to the needs of the paralysis community.
Maggie becomes only the second female CEO in the Reeve Foundation’s history, with it set to embark on its 40th anniversary year in 2022.
At 16 years old, Maggie broke her C2 vertebrae as a passenger in a car accident. She recovered fully, but her injury set her on a mission-driven career path to work on behalf of the paralysis community.
Working closely with Christopher and Dana Reeve, she helped establish the only national paralysis-focused organisation centreed around a dual mission – Today’s Care. Tomorrow’s Cure®.
“Throughout my career, my mission has been to ensure that people living with paralysis are supported to live empowered and independent lives,” she says.
“As CEO, I will continue to advocate and push to accelerate research toward cures, expand community outreach, and provide resources to elevate the voices and needs of our community and achieve greater representation. Those living with paralysis must have a seat at the table to achieve real equality.”
Maggie has dedicated over 20 years to the Reeve Foundation and its community, holding numerous executive roles at the Foundation during her tenure.
Most recently, she served as Chief Operating Officer, providing the leadership, management, and vision to strategically grow the organisation. Prior to that, she served as Vice President of Policy and Programs, which included overseeing the Foundation’s National Paralysis Resource Center (PRC).
The PRC – funded by an $8.7 million-dollar federal cooperative agreement from the Administration for Community Living, part of the U.S. Department of Health and Human Services – provides comprehensive information, resources and referral services to individuals impacted by paralysis.
Since its opening in 2002, more than 110,000 people have received one-on-one assistance from the PRC, accessing vast resources and free personalised support from its programs. Goldberg has also served as Senior Vice President of Marketing and Communications, a position she held for 13 years.
Among Maggie’s highest priorities in her new role is launching a modern approach to the Foundation’s scientific endeavours – a new platform for funding collaborative research from the bench to the bedside, designed to address key roadblocks along the scientific continuum and accelerate progress toward meaningful therapeutics.
In the past 40 years scientific research begun in earnest to address SCI and today innovative therapies and cures are finally in sight.
“The Reeve Foundation has long focused on uniting the brightest minds in the field to develop and deliver real-world treatments that will move the field closer to cures for spinal cord injury,” says Maggie.
“Now, more than ever, this requires global coordination and collaboration among SCI stakeholders, scientific and medical leadership, regulatory bodies and purposeful investors.
“Also paramount to clinical translation is an ecosystem and funding that supports all aspects of therapeutic development – from clinical trial design to regulatory approval to reimbursement, and more.
“Novel partnerships between advocacy groups and medical innovators can more effectively drive solutions forward to market. Success lies in the creation of collaborative frameworks designed to overcome traditional hurdles and dramatically speed the pace of progress.”
Jay Shepard, board Chair, Reeve Foundation, adds: “Maggie has been a devoted and powerful presence within the Foundation and for the spinal cord injured community, providing hands-on support and partnership for more than 20 years.
“Her expertise, dedication, and passion will be invaluable in her role as CEO as we advance our mission to bring tangible cures and treatments to the community and improve the lives of all those impacted by paralysis.
“There was no one better suited to lead this revered organisation, and I’m excited to continue working alongside her in this new chapter for the Reeve Foundation.”
Rediscovering sex and intimacy after CES
A first-of-its-kind psychosexual therapy service is supporting people living with Cauda Equina Syndrome and their partners
People living with Cauda Equina Syndrome (CES) are being supported in rediscovering their sex and intimate lives through the launch of a first-of-its-kind therapy service.
Sexual dysfunction is a common effect of CES, along with loss of sensation and issues around fertility, but a lack of specialist provision makes it something that is rarely addressed.
Now, to help address issues around sexual and intimate problems, a psychosexual therapy service has been created by Michelle Donald and Sue Lennon, working in conjunction with the Cauda Equina Champions Charity.
Despite its life-changing impact, CES as a condition is not widely known about even, meaning many people suffer in silence through a lack of diagnosis or appropriate support.
The syndrome is a rare and severe type of spinal stenosis where the nerves in the lower back suddenly become severely compressed, and failure to diagnose and receive appropriate treatment can lead to greater risk of long-term consequences including incontinence or paralysis.
It can have a devastating impact on people’s intimate lives through the ramifications of saddle numbness, pain, bladder and bowel issues and body image, which can impact significantly on personal relationships.
Through the creation of the psychosexual therapy service, Michelle and Sue, both expert professionals in their field, will support people in overcoming psychological barriers to help rebuild satisfying intimate lives and help them come to terms with their ‘new self’.
The charity will help fund this support for CES patients and their partner to explore new ways of enjoying sex and intimacy after life-changing injury.
Claire Thornber, founder of the Cauda Equina Champions Charity, is a passionate campaigner for greater support and awareness around CES, and recognises the huge impact sexual and intimacy problems can have on the lives of couples.
“As a former CES patient, I am all too aware of the impact of sexual dysfunction arising from a Cauda Equina injury,” she tells NR Times.
“On a daily basis, through our charity we hear of the struggles people face adjusting to life after CES. There is a huge human element to this, it’s not just about the surgery and medical impact. Many people resign themselves to withdrawing from any kind of intimacy and often relationships are put under huge pressure.
“We want to support couples and families to move forward together and empower the person living with CES to address this. For some people after CES, sex can be the last thing they want to think about and it is put on the back burner, but we are here for when they are ready.
“We are delighted to be able to offer this much-needed, crucial service, we’ve had some really good feedback from clinicians about what we have created.
“Also, we’re thrilled to be supported by Michelle and Sue, who bring with them years of experience in this area, helping people lead happy and fulfilling lives once again.”
“What a thrill it is for me to work with people who are truly curious about sexual satisfaction after CES,” says Sue.
“I really can’t wait to get started, joining Champion’s Charity in making a real difference and finding very happy outcomes.”
Michelle adds: “Having a low level spinal injury in my late 20s, I became aware of the many issues surrounding how an SCI affects a person’s relationships and sensuality.
“Provisions in the NHS are sadly very few. I am delighted to be able to offer this service to enable people to start a different intimate journey.”
Referrals can be made to the charity at email@example.com or via the helpline on 03335 777113
Trials of ONWARD spinal cord therapy deliver early boost
One patient paralysed for years is now moving his arms and toes following ARC Therapy
Trials of revolutionary ONWARD spinal cord therapy which is set to transform the lives of people living with paralysis are delivering strong early results, with reports of participants regaining movement in their arms and toes.
ARC Therapy is being trialled in sites around the world, including in the NHS Greater Glasgow and Clyde (NHSGGC) in a first-of-its-kind study in the UK.
The treatment, developed by ONWARD, uses tiny non-invasive electric pulses to improve connections across the damaged area of the spinal cord, with the ambition of delivering life-changing outcomes through restoring limb function for people who are tetraplegic or paralysed from the neck down.
The trials, part of the global Up-LIFT study run by ONWARD, are the latest step in the development of the ARC EX and ARC IM technologies, the first of which could be commercially available as early as 2023.
Dr Mariel Purcell, consultant in spinal injuries at NHSGGC who is leading the study at the Spinal Injuries Unit at the Queen Elizabeth University Hospital, said: “This is a really exciting research project involving a piece of kit that is completely non-invasive.
“We’ve had a lot of interest – from patients and other spinal injuries clinics around the UK, and further afield. We’ve even been contacted by a patient from the south of England, who is prepared to relocate here just to take part in the study.”
Initial results are promising, says Dr Purcell, and are helping to show that the introduction of ARC Therapy earlier in a person’s rehabilitation could deliver significant benefits.
“One patient who we have treated with the device was injured playing rugby at the age of 16 and had been completely paralysed from the neck down since,” she said.
“After the treatment, he had no problems with bladder or temperature control, he could move his big toes, and he can use his arms enough to operate a mobile phone.”
The first half of the study involves eight weeks of intensive therapy to optimise upper limb movement and function. During the second phase of the study, participants will receive non-invasive stimulation of the spinal cord in addition to traditional upper limb therapy for a further eight weeks.
The ARC therapy device works by improving the connections between healthy areas by placing electrodes on the skin that activate the nerves below the level of the injury, making the body more receptive to hand and arm movements.
The aim of the treatment is to help people regain some use of their arms and hands, but it may also improve bladder and bowel function, along with blood pressure control and temperature regulation.
NHSGGC said the participants in the study have received all the rehabilitation and treatment currently available and are living as independently as they can.
The study in Glasgow is recruiting participants until end of the year and it is hoped the final results of the study will be available later next year.
World-leading hospital secures funding for SCI research
Craig Hospital becomes one of only two centres in the United States to be continuously funded as an SCIMS since 1974
A world-renowned neurorehabilitation and research hospital for people with brain and spinal cord injury (SCI) has secured further funding to serve as a Spinal Cord Injury Model Systems (SCIMS) centre.
Craig Hospital becomes one of only two specialist centres in the United States to be continuously funded as an SCIMS since 1974 and enables it to advance its pioneering work further still.
The five-year, $2.4million grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) provides funding for Craig to conduct research that assesses the long-term outcomes of people who have sustained SCI.
Craig’s findings contribute to the National SCI Model Systems database, which has been in existence since 1973, while also proposing and participating in collaborative research studies focused on improving outcomes for individuals who have sustained SCI.
Throughout the course of the grant cycle, Craig has identified a number of objectives, including investigating the efficacy of various approaches to improve upper extremity function and trunk stability among individuals after cervical SCI and the evaluation of oral health status among the US SCI population.
The latest funding announcement is further endorsement of the world-leading work being done at Craig, which has been a pioneer in neurorehabilitation since 1956 and delivers stellar outcomes and a renewed view on what is possible in life to patients at its 93-bed facility in Colorado.
“We are extremely proud to have received this competitive grant from the NIDILRR yet again, as it designates Craig as both a clinical and a research centre of excellence,” said Candy Tefertiller, executive director of research and evaluation at Craig Hospital.
“Our team recognises the benefit of this grant every day, as we strive to translate our research findings to clinical care within our hospital, with the goal of improving the lives of our patients who have sustained SCI while also contributing knowledge to the greater field of SCI rehabilitation.”
There are 14 SCI Model Systems throughout the US, making up the largest network of research centres devoted to SCI in the world.
These centres collaborate on research and share knowledge and data that helps inform clinical treatment and rehabilitation.
As part of the designation, centres must have a comprehensive clinical service delivery program for patients who have sustained SCI in addition to the research component.
Inpatient rehab1 week ago
QEF appeal hits £1million milestone
Interviews4 weeks ago
Emilia Clarke’s SameYou – a catalyst for change
Insight1 week ago
How housing design can improve quality of life
News4 weeks ago
Robot with ‘potential to redefine neurorehab’ unveiled by Fourier
News4 weeks ago
Webinar to assess the Rehabilitation Prescription
News4 weeks ago
Sexual trauma ‘could lead to neurological conditions’
News4 weeks ago
Zen Koh takes on global change-maker role
Brain injury3 weeks ago
Blood test set to transform detection of brain damage after head injury